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Evaluation of the Release Profiles of Ibuprofen Formulated 




Purpose: To investigate the sustained release characteristics of 
ibuprofen lipospheres made from Capra hircus (GF) and carnauba 
wax (CW) in comparison with conventional granules as standard.  
Methods: Ibuprofen (90 g) and the lipid (30 g) were prepared by 
melt dispersion technique.  Conventional granules of ibuprofen 
were prepared with starch mucilage, 20% w/v. Resulting 
lipospheres were characterized with respect to sizes, flow property, 
bulk and tap densities, encapsulated in hard gelatin capsules and 
evaluated for drug release profiles.   
Results: Dissolution profile for lipospheres were a maximum drug 
release of 97% in 1 hr (conventional granules), 23% in 4 hr (GF), 
60% in 2 hr (CW) and 40% in admixtures of fats (GC). Admixing 
the fats enhanced flow properties of the lipospheres. Inclusion of a 
surfactant enhanced the release profiles from the lipospheres.  
Conclusion: Formulation of ibuprofen into lipospheres modified 
the release profile, which has implications in the formulation of 
sustained release multiunit dosage forms. 
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Various approaches have been adopted over the 
years to achieve sustained and/or extended 
release formulations of bioactive substances with 
short biologic half-life (t
1/2
).   Such drugs require 
frequent administration, which results in certain 
drawbacks such as lack of compliance to dosage 
regime and increased chances of unwanted side 
effects [1-3]. The commonest approach to sustain 
the release of drugs is spheronization followed by 
film coating; film coating with water insoluble 
polymers such as acrylatemethacrylate 
copolymers and ethylcellulose. However, film 
coating with organic solvents are cumbersome, 
expensive and they are not environmentally 
friendly [4-7]. 
  
In order to minimize the cumbersome problems 
of frequent dosing and side effects, the need to 
prolong the plasma half-life (t
1
/2) of the drug by 
formulation into sustained release preparation 
becomes very crucial for such drugs.  Ibuprofen 
is a non-steroidal anti - inflammatory drug 
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(NSAIDs) used extensively in the treatment and 
management of rheumatoid arthritis and 
osteoarthritis conditions.  Its short biologic half-
life is only 1.8 - 2 hours and it is often 
administered orally at a dose of 200 - 400mg 
every four to six hours daily and its dosing 
frequency makes it an ideal drug candidate that 
requires sustained release formulation. Side 
effects frequently reported of NSAIDs include 
gastrointestinal irritation, nausea and dyspepsia, 
thrombocytopenia [8-9].  Hence the objective of 
this study was to design sustained release 
formulation of ibuprofen into lipospheres using 
carnuba wax (CW) and/or homolipids extracted 
from Capra hircus (goat; GF) for sustained 
release system. Lipospheres are solid 
microparticulate dispersion composed of a 
hydrophobic fat and drug of size range 0.2 – 1000 
µm [10]. The influence of inclusion of surfactant 
on the release profile, the packing and flow 
properties will also be investigated. 
 




The test drug Ibuprofen was received as a gift 
from Emzor Pharmaceutical Company Ltd, Lagos 
Nigeria. Carnuba wax (Halewood Chemicals Ltd, 
England) a fine waxy solid, pale yellow in colour, 
with melting point 80-88
0
C was used as a 
standard pharmaceutical wax.  The homolipid fat 
from Capra hircus (GF) was obtained locally 
from an abattoir in Benin City, Nigeria.  All other 
reagents were of analytical grade.  
 
Extraction and purification of the homolipid 
from Capra hircus (GF) 
 
The homolipid extraction followed the modified 
procedure described in an earlier study [11]. The 
extraneous materials were manually separated 
from the adipose tissue that was grated and 
subjected to moist heat by boiling with half its 
weight of water in a stainless steel vessel 
immersed in a water bath maintained at 90 
o
C for 
45 mins. The molten fat was separated from the 
aqueous phase after filtration. The fat obtained 
was deodorized by treatment with activated 
charcoal to obtain a dull-whitish clump fat stable 
and suitable for drug delivery. 
 
Preparation of the liposheres  
 
Batches containing the appropriate quantities of 
the drugs (90 g) and the lipids (30 g) (CW or GF 
or the admixture of both) in the proportional ratio 
of 3:1 (i.e. drug: lipid) and/or the surfactant 
(tween 80) were melted together to form a 
homogenous mixture. The mixture was 
precipitated with water over ice chips in a water 
bath maintained at 4 
o
C to form the lipospheres 
[12] while conventional granules were made with 
20% 
w
/v starch mucilage. The resulting 
lipospheres were filtered out, washed with more 
water and dried at room temperature 28 
o
C for 48 
hours and stored in an airtight desicator activated 
with silica gel overnight before their evaluation.  
Lipospheres were evaluated for their physical and 
micromeritic properties as follows: 
 
Evaluation of degree of entrapment efficiency 
 
Lipospheres (100 g) were soaked in 100ml of 
distilled water maintained at 40 
o
C over night 
with occasional stirring. The resulting solution 
was cooled to 0 
o
C in a refridgerator and analysed 
spectrophotometrically at 265 nm for ibuprofen 
content. The percentage efficiency was obtained 
from the equation: 




⋅⋅ x 100                    (1) 
 
Determination of tapped and bulk densities 
 
The bulk and tapped densities (BD and TD) were 
determined by standard procedures and the data 
substituted into the following equation to obtain 
the compressibility index (CI) [13]: 
CI = 
TD
xBDTD %100)( −                 (2) 
 
Flow properties of the lipospheres 
 
The flow characteristics of lipospheres was 
evaluated by funnel method which determined the 
angle of repose obtained when a sample of 
powder (10 g) was allowed to fall freely from the 
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Table 1: Physical properties of lipospheres and conventional granules 
 
Parameters evaluated Conventional 
granule 





Angle of repose (θ0) 15.13 38.13±2.1 27.3±1.3 21.6 23.10 
Bulk density (gcm-3) 0.32±0.02 0.27 0.476 0.370 0.321 
Tapped density (g.cm-3) 0.51±0.03 0.318 0.588 0.446 0.407 
Compressibility index (CI) 37.25±2.1 15.09 19.05 17.01 21.10 
Entrapment efficiency (%) -- 23.0 69.0 85.6 72.0 
 
stem of a funnel to a horizontal surface [14]. The 
radius (r) and height (H) of the powder bed were 
determined and the angle of repose (θ) was 
estimated using the expression: 
θ     =    arc tan 
r
H
              (3) 
 
Particle size distribution 
 
The size distribution of lipospheres and 
conventional granules were carried out by sieve 
analysis mounting a series of test sieves ranging 
in pore size 212 µm –1.7mm in a sieve shaker 
(Endicott’s Ltd, UK). Fractions retained on each 
sieve were weighed and the percentage frequency 
for each size distribution determined. 
 
Encapsulation of the granules and 
lipospheres 
 
A 200mg sample of the granules or lipospheres 
was filled manually into empty hard gelatin 
shells of 250mg capacity. The capsules were 
stored over night in airtight containers before 




Each capsule (200 mg) of the lipospheres or the 
granules was placed in a cylindrical basket 
(aperture size 425 µm, diameter 20 mm, and 
height 30 mm) and immersed in 1000 ml 0.1N 
HCl maintained at 37± 1 
o
C and stirred at 100 
rpm with a single blade stirrer (GallenKamp 
stirrer; model APP N0 4B 5784A. Cat N0: 
SS530). At selected intervals, 5 ml samples were 
withdrawn with a pipette fitted with a cotton 
plug, diluted and analysed spectrophotometrically 
at λmax 265mn for ibuprofen content (PG 
Instruments Ltd England, model T70). In the case 
of the lipospheres, samples were refrigerated over 
night to allow solidification of the leached fat 
before assaying for ibuprofen content. All 
determinations were carried out in triplicate, and 
the amounts of drug released were expressed as 
percentage of initial drug content and mean 




Physical properties of the liposheres and the 
granules 
 
Treatment of the extracted goat fat (GF) with 
activated charcoal brought about a remarkable 
reduction in the inocuous odour. Results of the 
physical properties of lipospheres and the 
conventional granules are shown in Table 1.   The 
percentage entrapment efficiency obtained from 
GF lipospheres alone was very low (i.e. < 25%). 
CW wax alone, their admixture (GC) and with 
surfactant GC+T.80 gave higher percentage 
entrapment efficiencies (i.e. 69, 86 and 72%, 
respectively). The conventional granules 
exhibited satisfactory flow properties as revealed 
by the low angle of repose (<150), while the 
lipospheres exhibited very poor flow properties 
with angle of repose ranging from 31-35
0
. Carr 
index (CI) values of the liposomes were <23% 
which were low when compared with the 
conventional granules with CI value > 40%. 
Generally, the particle size ranged from 212 – 
1700 µm for both conventional granules and the 
lipospheres. The modal class size generally was 
1000µm. Data of release profiles from 
conventional granules and lipospheres are shown 
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in figure 1. The conventional granules gave the 
highest release with a maximum release of 97% 
of the total pay load and the time taken to achieve 
this maximum release (t∞) was 1hr. GF 
lipospheres exhibited very low percentage 
entrapment efficiency (< 25%) again the release 
rates were markedly retarded.  Generally, the 
release from lipospheres made from CW and/or 
the admixture (GC) were markedly retarded, and 
the dissolution rates %h
-1
; (Table 2) ranged as 
follows: 21.6 (conventional granules), 14.1 (CW 
lipospheres), 6.3 (GF liposphes), 5.6 (GC 






























Figure 1: Dissolution profiles of ibuprofen released 
from the 250mg capsules: (Ο) Conventional granules, 
(•) CW only, (∆) GF only, (▪) Admixture GC, and ( ) 
GC +T.80  
 
Table 2: Dissolution rate profiles of conventional 
granules and lipospheres 
 
Granule type Dissolution 
rate (%h-1) 
Conventional granules 21.6 
Goat alone (GF) 6.3 
Carnauba wax alone (CW) 14.1 
Admixture (goat & carnauba fats; 
GC) 
5.6 




Low entrapment efficiency from GF have been 
observed in this study that may be attributed to 
the stiff consistency of GF. The admixture GC 
(3:1) yielded the highest entrapment efficiency 
which may be attributed to the texture and/or 
consistency modification. It does appear that the 
poor flow property which was more remarkably 
low with GF than CW is due to the clustering and 
sticking behaviour observed in the lipospheres 
prepared with GF. Preliminary investigations of 
the texture and structural compositions of the fats 
as revealed by the viscosity indices showed that 
GF was of a stiffer consistency than CW and/or 
their admixtures GC. Their viscosity indices were 
in the following range: GF (4800s) >>CW 
(3200s) > GC (2600s) respectively.  
 
Carr index (CI) value (Table 1) showed that the 
lipospheres were not compressible since earlier 
preliminary investigations revealed poor flow 
properties, sticking and clustering. 
 
Particle size distribution 
 
There was a slight difference in the particle size 
distribution between the conventional granules 
and the lipospheres which was not statistically 
significant. Also, the composition of the fat had 
no significant influence on the size distribution of 
the lipospheres. 
 
Drug release characteristics 
 
Generally, the lipospheres displayed retarded 
drug release while the conventional granules 
displayed a rapid dissolution of the drug from the 
surface of the granules. The retarded release 
exhibited by the lipospheres may be attributed to 
the poor influx of the aqueous leaching fluid into 
the matrix core of the lipospheres. Fats and waxes 
being hydrophobic in nature impair rapid influx 
of the leaching fluid into such matrix-structured 
core. However, the inclusion of surfactant 
(Tween 80; T.80) is known to enhance the release 
of drugs from the lipospheres. The presence of a 
surfactant in the core of the lipospheres promoted 
the release of the hydrophobic drug from the core 
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of the liposphere by enhancing the solubilization 




Formulation of ibuprofen into lipospheres using 
homolipid fat from Capra hircus (goat fat) causes 
low drug entrapment efficiency and the resulting 
lipospheres may display poor flow properties 
compared with the standard pharmaceutical fat, 
carnauba wax. The admixtures of the fats will 
produce higher percentage entrapment efficiency 
and produce flow properties quite similar to those 
of carnauba wax.  
 
The enhanced release profiles exhibited by the 
inclusion of surfactant has important implications 
in the formulation of sustained release where a 
prompt onset of action may be desired followed 
by extended maintenance release especially in 
conditions of excruciating painful conditions such 
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